Healthy Living: Life Outside The Bubble
For years, doctors have been searching for a better way to treat children born without an immune system.
The standard treatment, bone marrow transplant, comes with risk of serious infection.
Researchers are testing a new treatment that could be a game changer.
It’s still early in the trial, but doctors say Ja’ceon’s prognosis is very promising.
The trial will treat at least 15 children at UCSF over the next five years that have the same x-linked version of the disease as Ja’ceon.
SCID develops in about one in every 60,000 newborn in the U.S., of which about 25 percent have this x-linked form of the disease.